Meta-Analysis of Net Long-Term Benefit of Different Therapeutic Strategies in Patients With Cryptogenic Stroke and Patent Foramen Ovale

Published:January 05, 2015DOI:
      We pooled available data on follow-up events in patients with patent foramen ovale and cryptogenic stroke to evaluate the net clinical benefit of different therapeutic strategies (percutaneous closure vs antiplatelet vs anticoagulant therapy). MEDLINE/PubMed and Cochrane databases and reviewed cited references to identify relevant studies were used; 3,311 patients from 21 clinical studies, both observational and randomized, with follow-up ≥12 months were overall included. Net clinical benefit was evaluated considering the cumulative incidence of both stroke and/or transient ischemic attack and major bleeding events. Anticoagulant therapy was more effective than antiplatelet therapy in preventing recurrent stroke and/or transient ischemic attack (event rates: 7.7% vs 9.8%, respectively, p = 0.03), but at the price of more than sixfold greater risk of major bleeding (7.1% vs 1.3%; odds ratio 6.49, 95% confidence interval 3.25 to 12.99, p <0.00001). Patent foramen ovale closure was associated over the long term with significant net clinical benefit versus both antiplatelet and anticoagulant therapy; such benefit was driven by 50% relative reduction of stroke and/or transient ischemic attack versus antiplatelet therapy and by 82% relative reduction of major bleeding versus anticoagulant therapy. In conclusion, results of this large study-level meta-analysis may influence practice patterns in patients with patent foramen ovale and cryptogenic stroke; an individualized approach tailored on both the risk of recurrent cerebral events and the bleeding risk should be used to identify the best therapeutic option (percutaneous closure vs antiplatelet therapy vs anticoagulant therapy).
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to American Journal of Cardiology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Nagaraja V.
        • Eslick G.D.
        Stroke prevention by percutaneous closure of patent foramen ovale: a meta-analytic review.
        Int J Cardiol. 2014; 172: 524-526
        • Furlan A.J.
        • Reisman M.
        • Massaro J.
        • Mauri L.
        • Adams H.
        • Albers G.W.
        • Felberg R.
        • Herrmann H.
        • Kar S.
        • Landzberg M.
        • Raizner A.
        • Wechsler L.
        • CLOSURE I Investigators
        Closure or medical therapy for cryptogenic stroke with patent foramen ovale.
        N Engl J Med. 2012; 366: 991-999
        • Carroll J.D.
        • Saver J.L.
        • Thaler D.E.
        • Smalling R.W.
        • Berry S.
        • MacDonald L.A.
        • Marks D.S.
        • Tirschwell D.L.
        • RESPECT Investigators
        Closure of patent foramen ovale versus medical therapy after cryptogenic stroke.
        N Engl J Med. 2013; 368: 1092-1100
        • Meier B.
        • Kalesan B.
        • Mattle H.P.
        • Khattab A.A.
        • Hildick-Smith D.
        • Dudek D.
        • Andersen G.
        • Ibrahim R.
        • Schuler G.
        • Walton A.S.
        • Wahl A.
        • Windecker S.
        • Jüni P.
        • PC Trial Investigators
        Percutaneous closure of patent foramen ovale in cryptogenic embolism.
        N Engl J Med. 2013; 368: 1083-1091
        • Kitsios G.D.
        • Dahabreh I.J.
        • Abu Dabrh A.M.
        • Thaler D.E.
        • Kent D.M.
        Patent foramen ovale closure and medical treatments for secondary stroke prevention: a systematic review of observational and randomized evidence.
        Stroke. 2012; 43: 422-431
        • Agarwal S.
        • Bajaj N.S.
        • Kumbhani D.J.
        • Tuzcu E.M.
        • Kapadia S.R.
        Meta-analysis of transcatheter closure versus medical therapy for patent foramen ovale in prevention of recurrent neurological events after presumed paradoxical embolism.
        JACC Cardiovasc Interv. 2012; 5: 777-789
        • Guyatt G.H.
        • Akl E.A.
        • Crowther M.
        • Gutterman D.D.
        • Schuünemann H.J.
        • American College of Chest Physicians Antithrombotic Therapy and Prevention of Thrombosis Panel
        Executive summary: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines.
        Chest. 2012; 141: 7S-47S
      1. Higgins J.P.T. Green S. Cochrane Handbook for Systematic Reviews of Interventions 4.2.5. John Wiley & Sons, Chichester, UK2005
        • Mantel N.
        • Haenszel W.
        Statistical aspects of the analysis of data from retrospective studies of disease.
        J Natl Cancer Inst. 1959; 22: 719-748
        • Higgins J.P.
        • Thompson S.G.
        • Deeks J.J.
        • Altman D.G.
        Measuring inconsistency in meta-analyses.
        BMJ. 2003; 327: 557-560
        • Begg C.B.
        • Mazumdar M.
        Operating characteristics of a rank correlation test for publication bias.
        Biometrics. 1994; 50: 1088-1101
        • Hanna J.P.
        • Sun J.P.
        • Furlan A.J.
        • Stewart W.J.
        • Sila C.A.
        • Tan M.
        Patent foramen ovale and brain infarct. Echocardiographic predictors, recurrence, and prevention.
        Stroke. 1994; 25: 782-786
        • Mas J.L.
        • Zuber M.
        Recurrent cerebrovascular events in patients with patent foramen ovale, atrial septal aneurysm, or both and cryptogenic stroke or transient ischemic attack. French Study Group on Patent Foramen Ovale and Atrial Septal Aneurysm.
        Am Heart J. 1995; 130: 1083-1088
        • Hausmann D.
        • Mügge A.
        • Daniel W.G.
        Identification of patent foramen ovale permitting paradoxic embolism.
        J Am Coll Cardiol. 1995; 26: 1030-1038
        • Bogousslavsky J.
        • Garazi S.
        • Jeanrenaud X.
        • Aebischer N.
        • Van Melle G.
        Stroke recurrence in patients with patent foramen ovale: the Lausanne Study. Lausanne Stroke with Paradoxal Embolism Study Group.
        Neurology. 1996; 46: 1301-1305
        • Cujec B.
        • Mainra R.
        • Johnson D.H.
        Prevention of recurrent cerebral ischemic events in patients with patent foramen ovale and cryptogenic strokes or transient ischemic attacks.
        Can J Cardiol. 1999; 15: 57-64
        • Mas J.L.
        • Arquizan C.
        • Lamy C.
        • Zuber M.
        • Cabanes L.
        • Derumeaux G.
        • Coste J.
        • Patent Foramen Ovale and Atrial Septal Aneurysm Study Group
        Recurrent cerebrovascular events associated with patent foramen ovale, atrial septal aneurysm, or both.
        N Engl J Med. 2001; 345: 1740-1746
        • Homma S.
        • Sacco R.L.
        • Di Tullio M.R.
        • Sciacca R.R.
        • Mohr J.P.
        • PFO in Cryptogenic Stroke Study (PICSS) Investigators
        Effect of medical treatment in stroke patients with patent foramen ovale: patent foramen ovale in Cryptogenic Stroke Study.
        Circulation. 2002; 105: 2625-2631
        • Windecker S.
        • Wahl A.
        • Nedeltchev K.
        • Arnold M.
        • Schwerzmann M.
        • Seiler C.
        • Mattle H.P.
        • Meier B.
        Comparison of medical treatment with percutaneous closure of patent foramen ovale in patients with cryptogenic stroke.
        J Am Coll Cardiol. 2004; 44: 750-758
        • Schuchlenz H.W.
        • Weihs W.
        • Berghold A.
        • Lechner A.
        • Schmidt R.
        Secondary prevention after cryptogenic cerebrovascular events in patients with patent foramen ovale.
        Int J Cardiol. 2005; 101: 77-82
        • Harrer J.U.
        • Wessels T.
        • Franke A.
        • Lucas S.
        • Berlit P.
        • Klötzsch C.
        Stroke recurrence and its prevention in patients with patent foramen ovale.
        Can J Neurol Sci. 2006; 33: 39-47
        • Thanopoulos B.V.
        • Dardas P.D.
        • Karanasios E.
        • Mezilis N.
        Transcatheter closure versus medical therapy of patent foramen ovale and cryptogenic stroke.
        Catheter Cardiovasc Interv. 2006; 68: 741-746
        • Cerrato P.
        • Priano L.
        • Imperiale D.
        • Bosco G.
        • Destefanis E.
        • Villar A.M.
        • Ribezzo M.
        • Trevi G.P.
        • Bergamasco B.
        • Orzan F.
        Recurrent cerebrovascular ischaemic events in patients with interatrial septal abnormalities: a follow-up study.
        Neurol Sci. 2006; 26: 411-418
        • Casaubon L.
        • McLaughlin P.
        • Webb G.
        • Yeo E.
        • Merker D.
        • Jaigobin C.
        Recurrent stroke/TIA in cryptogenic stroke patients with patent foramen ovale.
        Can J Neurol Sci. 2007; 34: 74-80
        • Serena J.
        • Marti-Fàbregas J.
        • Santamarina E.
        • Rodríguez J.J.
        • Perez-Ayuso M.J.
        • Masjuan J.
        • Segura T.
        • Gállego J.
        • Dávalos A.
        • CODICIA, Right-to-Left Shunt in Cryptogenic Stroke Study
        • Stroke Project of the Cerebrovascular Diseases Study Group
        • Spanish Society of Neurology
        Recurrent stroke and massive right-to-left shunt: results from the prospective Spanish multicenter (CODICIA) study.
        Stroke. 2008; 39: 3131-3136
        • Lee J.Y.
        • Song J.K.
        • Song J.M.
        • Kang D.H.
        • Yun S.C.
        • Kang D.W.
        • Kwon S.U.
        • Kim J.S.
        Association between anatomic features of atrial septal abnormalities obtained by omni-plane transesophageal echocardiography and stroke recurrence in cryptogenic stroke patients with patent foramen ovale.
        Am J Cardiol. 2010; 106: 129-134
        • Paciaroni M.
        • Agnelli G.
        • Bertolini A.
        • Pezzini A.
        • Padovani A.
        • Caso V.
        • Venti M.
        • Alberti A.
        • Palmiero R.A.
        • Cerrato P.
        • Silvestrelli G.
        • Lanari A.
        • Previdi P.
        • Corea F.
        • Balducci A.
        • Ferri R.
        • Falcinelli F.
        • Filippucci E.
        • Chiocchi P.
        • Grandi F.C.
        • Ferigo L.
        • Musolino R.
        • Bersano A.
        • Ghione I.
        • Sacco S.
        • Carolei A.
        • Baldi A.
        • Ageno W.
        • FORI (Foramen Ovale Registro Italiano) Investigators
        Risk of recurrent cerebrovascular events in patients with cryptogenic stroke or transient ischemic attack and patent foramen ovale: the FORI (Foramen Ovale Registro Italiano) study.
        Cerebrovasc Dis. 2011; 31: 109-116
        • Mazzucco S.
        • Bovi P.
        • Carletti M.
        • Tomelleri G.
        • Golia G.
        • Stegagno C.
        • Variola A.
        • Anselmi M.
        • Nicolis D.
        • Olivato S.
        • Anzola G.P.
        • Ribichini F.
        • VEROSTROKE Study Group
        A model of multi-disciplinary approach to the diagnosis and treatment of young patients with cryptogenic stroke and patent foramen ovale.
        Cardiol Young. 2012; 22: 327-334
        • Wahl A.
        • Jüni P.
        • Mono M.L.
        • Kalesan B.
        • Praz F.
        • Geister L.
        • Räber L.
        • Nedeltchev K.
        • Mattle H.P.
        • Windecker S.
        • Meier B.
        Long-term propensity score-matched comparison of percutaneous closure of patent foramen ovale with medical treatment after paradoxical embolism.
        Circulation. 2012; 125: 803-812